scispace - formally typeset
V

Vinod Kumar Verma

Researcher at Centre for Cellular and Molecular Biology

Publications -  27
Citations -  238

Vinod Kumar Verma is an academic researcher from Centre for Cellular and Molecular Biology. The author has contributed to research in topics: Cancer & Stem cell. The author has an hindex of 8, co-authored 26 publications receiving 190 citations. Previous affiliations of Vinod Kumar Verma include Council of Scientific and Industrial Research & Global Hospitals Group.

Papers
More filters
Journal ArticleDOI

OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer

TL;DR: OncomiRdbB is a comprehensive and integrated database of oncomiRs and their targets in breast cancer with multiple query options which will help enhance both understanding of the biology of breast cancer and the development of new and innovative microRNA based diagnostic tools and targets of therapeutic significance.
Journal ArticleDOI

Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.

TL;DR: Chimeric or humanized anti-HM1.24 mAbs have potential as a new therapeutic tool in lung cancer, and in combination with interleukins and interferons, could be useful for enhancing ADCC.
Journal ArticleDOI

Effect of physical exercise on tumor growth regulating factors of tumor microenvironment: implications in exercise-dependent tumor growth retardation.

TL;DR: The role of oxygen, pH, lactate and cytokines of tumor micro-environment associated with physical exercise-dependent alteration in the growth properties of tumor cells is investigated to explore their contribution in modulation of tumor.
Journal ArticleDOI

Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging.

TL;DR: The approach to develop a nanoprobe for cell selection and imaging with a direct therapeutic translational focus has the potential to achieve moderate to high specific cell selection for the dual purpose of imaging and therapy.